These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 29370420
41. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation. Carrara C, Podestà MA, Abbate M, Rizzo P, Piras R, Alberti M, Daina E, Ruggenenti P, Remuzzi G, on behalf of the EAGLE Study Group. Nephron; 2020; 144(4):195-203. PubMed ID: 32050203 [Abstract] [Full Text] [Related]
43. C3 glomerulonephritis with a severe crescentic phenotype. Ravindran A, Fervenza FC, Smith RJH, Sethi S. Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446 [Abstract] [Full Text] [Related]
45. C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report. Wen J, Wang W, Xu F, Sun J, Chen J, Ni X. BMC Nephrol; 2018 Jun 25; 19(1):148. PubMed ID: 29940891 [Abstract] [Full Text] [Related]
49. Atypical hemolytic uremic syndrome recurrence after kidney transplantation. Matar D, Naqvi F, Racusen LC, Carter-Monroe N, Montgomery RA, Alachkar N. Transplantation; 2014 Dec 15; 98(11):1205-12. PubMed ID: 24933457 [Abstract] [Full Text] [Related]
50. Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report. Deshayes S, Martin Silva N, Chatelet V, Chantepie S, Le Quintrec M, Comoz F, Bridoux F, Dragon-Durey MA, Aouba A. Clin Rheumatol; 2018 Apr 15; 37(4):1119-1122. PubMed ID: 29516279 [Abstract] [Full Text] [Related]
51. Blockade of C5 in Severe Acute Postinfectious Glomerulonephritis Associated With Anti-Factor H Autoantibody. Chehade H, Rotman S, Frémeaux-Bacchi V, Aubert V, Sadallah S, Sifaki L, Salomon R, Pascual M. Am J Kidney Dis; 2016 Dec 15; 68(6):944-948. PubMed ID: 27683044 [Abstract] [Full Text] [Related]
52. Complement dysregulation in glomerulonephritis. Kaartinen K, Safa A, Kotha S, Ratti G, Meri S. Semin Immunol; 2019 Oct 15; 45():101331. PubMed ID: 31711769 [Abstract] [Full Text] [Related]
53. C3 glomerulopathy - understanding a rare complement-driven renal disease. Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM. Nat Rev Nephrol; 2019 Mar 15; 15(3):129-143. PubMed ID: 30692664 [Abstract] [Full Text] [Related]
54. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy. Williams AL, Gullipalli D, Ueda Y, Sato S, Zhou L, Miwa T, Tung KS, Song WC. Kidney Int; 2017 Jun 15; 91(6):1386-1397. PubMed ID: 28139294 [Abstract] [Full Text] [Related]
58. C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis. Ponticelli C, Calatroni M, Moroni G. Front Med (Lausanne); 2023 Jun 15; 10():1289812. PubMed ID: 38076230 [Abstract] [Full Text] [Related]
59. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. Sartz L, Olin AI, Kristoffersson AC, Ståhl AL, Johansson ME, Westman K, Fremeaux-Bacchi V, Nilsson-Ekdahl K, Karpman D. J Immunol; 2012 Feb 15; 188(4):2030-7. PubMed ID: 22250080 [Abstract] [Full Text] [Related]
60. A case of atypical hemolytic uremic syndrome in a second renal transplant. Zwang NA, Ho B, Kanwar YS, Lewis B, Cusick M, Friedewald JJ, Gallon L. J Nephrol; 2018 Feb 15; 31(1):165-172. PubMed ID: 28224376 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]